Institutional members access full text with Ovid®

Share this article on:

The use of psychiatric drugs and worsening body mass index among inpatients with schizophrenia

Wang, Po-Shenga; Wu, Shang-Liangb; Ching, Han-Yia

International Clinical Psychopharmacology: July 2014 - Volume 29 - Issue 4 - p 235–238
doi: 10.1097/YIC.0000000000000027
Original Articles

The aim of the present study was to investigate the relationship between 10 psychotropic agents and worsening BMI from overweight to obesity among inpatients with schizophrenia. A total of 138 patients with schizophrenia were recruited in this retrospective study. We included 23 patients with worsening BMI, from overweight (24≤BMI<27 kg/m2) to obesity (BMI≥27 kg/m2), as the case group and 115 patients without a worse BMI as the control group. Data were analyzed to assess the relationships between psychiatric drug use and BMI that worsened from overweight to obesity. Of the 138 patients, 60.9% were men. Their mean age was 47.2±9.7 years, mean age of onset of disease was 32.2±10.4 years, and the mean length of illness 15.0±6.5 years. Valproic acid was found to have a significant impact on the worsening of BMI from overweight to obesity (P<0.05). Age at onset of disease, length of illness, and duration of hospitalization were not associated significantly with worsening of BMI from overweight to obesity. These results call for caution in using valproic acid in schizophrenic inpatients with BMIs indicating overweight or obesity.

aDepartment of Psychiatry, Tsao-Tun Psychiatric Center, Department of Health, Executive Yuan, Nantou County

bTaiwan Research Association of Health Care, Taichung, Taiwan

Correspondence to Han-Yi Ching, MSc, Department of Psychiatry, Tsao-Tun Psychiatric Center, Department of Health, Executive Yuan, No. 161 Yu-Ping Road, Tsao-Tun Township, Nantou County 542, Taiwan Tel: +886 911587276; fax: +886 492554138; e-mail:

Received July 16, 2013

Accepted December 3, 2013

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins